177 related articles for article (PubMed ID: 27742073)
1. Genetic evolution in chronic lymphocytic leukaemia.
Delgado J; Villamor N; López-Guillermo A; Campo E
Best Pract Res Clin Haematol; 2016 Mar; 29(1):67-78. PubMed ID: 27742073
[TBL] [Abstract][Full Text] [Related]
2. Detailed analysis of therapy-driven clonal evolution of TP53 mutations in chronic lymphocytic leukemia.
Malcikova J; Stano-Kozubik K; Tichy B; Kantorova B; Pavlova S; Tom N; Radova L; Smardova J; Pardy F; Doubek M; Brychtova Y; Mraz M; Plevova K; Diviskova E; Oltova A; Mayer J; Pospisilova S; Trbusek M
Leukemia; 2015 Apr; 29(4):877-85. PubMed ID: 25287991
[TBL] [Abstract][Full Text] [Related]
3. Targeted resequencing for analysis of clonal composition of recurrent gene mutations in chronic lymphocytic leukaemia.
Jethwa A; Hüllein J; Stolz T; Blume C; Sellner L; Jauch A; Sill M; Kater AP; te Raa GD; Geisler C; van Oers M; Dietrich S; Dreger P; Ho AD; Paruzynski A; Schmidt M; von Kalle C; Glimm H; Zenz T
Br J Haematol; 2013 Nov; 163(4):496-500. PubMed ID: 24032483
[TBL] [Abstract][Full Text] [Related]
4. Clonal evolution in chronic lymphocytic leukemia: impact of subclonality on disease progression.
Sutton LA; Rosenquist R
Expert Rev Hematol; 2015 Feb; 8(1):71-8. PubMed ID: 25345442
[TBL] [Abstract][Full Text] [Related]
5. Molecular pathogenesis of CLL and its evolution.
Rodríguez D; Bretones G; Arango JR; Valdespino V; Campo E; Quesada V; López-Otín C
Int J Hematol; 2015 Mar; 101(3):219-28. PubMed ID: 25630433
[TBL] [Abstract][Full Text] [Related]
6. [The genetic landscape of chronic lymphocytic leukemia].
Marosvári D; Alpár D; Király AP; Rajnai H; Reiniger L; Bödör C
Magy Onkol; 2016 Jun; 60(2):118-25. PubMed ID: 27275638
[TBL] [Abstract][Full Text] [Related]
7. Genetic and epigenetic basis of chronic lymphocytic leukemia.
Martín-Subero JI; López-Otín C; Campo E
Curr Opin Hematol; 2013 Jul; 20(4):362-8. PubMed ID: 23719185
[TBL] [Abstract][Full Text] [Related]
8. Targeted deep sequencing reveals clinically relevant subclonal IgHV rearrangements in chronic lymphocytic leukemia.
Stamatopoulos B; Timbs A; Bruce D; Smith T; Clifford R; Robbe P; Burns A; Vavoulis DV; Lopez L; Antoniou P; Mason J; Dreau H; Schuh A
Leukemia; 2017 Apr; 31(4):837-845. PubMed ID: 27795555
[TBL] [Abstract][Full Text] [Related]
9. Epigenetic and genetic alterations and their influence on gene regulation in chronic lymphocytic leukemia.
Huang D; Ovcharenko I
BMC Genomics; 2017 Mar; 18(1):236. PubMed ID: 28302063
[TBL] [Abstract][Full Text] [Related]
10. Genomic and Epigenomic Alterations in Chronic Lymphocytic Leukemia.
Nadeu F; Diaz-Navarro A; Delgado J; Puente XS; Campo E
Annu Rev Pathol; 2020 Jan; 15():149-177. PubMed ID: 31977296
[TBL] [Abstract][Full Text] [Related]
11. Genomic Instability and Clonal Evolution in Chronic Lymphocytic Leukemia: Clinical Relevance.
Condoluci A; Rossi D
J Natl Compr Canc Netw; 2020 Dec; 19(2):227-233. PubMed ID: 33383567
[TBL] [Abstract][Full Text] [Related]
12. Integrative NGS testing reveals clonal dynamics of adverse genomic defects contributing to a natural progression in treatment-naïve CLL patients.
Navrkalova V; Plevova K; Radova L; Porc J; Pal K; Malcikova J; Pavlova S; Doubek M; Panovska A; Kotaskova J; Pospisilova S
Br J Haematol; 2024 Jan; 204(1):240-249. PubMed ID: 38062779
[TBL] [Abstract][Full Text] [Related]
13. Chronic lymphocytic leukaemia genomics and the precision medicine era.
Ghamlouch H; Nguyen-Khac F; Bernard OA
Br J Haematol; 2017 Sep; 178(6):852-870. PubMed ID: 28444740
[TBL] [Abstract][Full Text] [Related]
14. Utilization of next generation sequencing identifies potentially actionable mutations in chronic lymphocytic leukaemia.
Wang J; Morrissette J; Lieberman DB; Timlin C; Schuster SJ; Mato AR
Br J Haematol; 2018 Jan; 180(2):299-301. PubMed ID: 27714764
[No Abstract] [Full Text] [Related]
15. Next-generation sequencing in chronic lymphocytic leukemia.
Villamor N; López-Guillermo A; López-Otín C; Campo E
Semin Hematol; 2013 Oct; 50(4):286-95. PubMed ID: 24246696
[TBL] [Abstract][Full Text] [Related]
16. Deciphering the molecular landscape in chronic lymphocytic leukemia: time frame of disease evolution.
Sutton LA; Rosenquist R
Haematologica; 2015 Jan; 100(1):7-16. PubMed ID: 25552678
[TBL] [Abstract][Full Text] [Related]
17. What does it mean I have a monoclonal B-cell lymphocytosis?: Recent insights and new challenges.
Scarfò L; Ghia P
Semin Oncol; 2016 Apr; 43(2):201-8. PubMed ID: 27040697
[TBL] [Abstract][Full Text] [Related]
18. SOHO State of the Art Updates and Next Questions: Clonal Evolution in Chronic Lymphocytic Leukemia.
Condoluci A; Rossi D
Clin Lymphoma Myeloma Leuk; 2020 Dec; 20(12):779-784. PubMed ID: 33039357
[TBL] [Abstract][Full Text] [Related]
19. Integrative epigenomics in chronic lymphocytic leukaemia: Biological insights and clinical applications.
Kulis M; Martin-Subero JI
Br J Haematol; 2023 Feb; 200(3):280-290. PubMed ID: 36121003
[TBL] [Abstract][Full Text] [Related]
20. Insight into genetic predisposition to chronic lymphocytic leukemia from integrative epigenomics.
Speedy HE; Beekman R; Chapaprieta V; Orlando G; Law PJ; Martín-García D; Gutiérrez-Abril J; Catovsky D; Beà S; Clot G; Puiggròs M; Torrents D; Puente XS; Allan JM; López-Otín C; Campo E; Houlston RS; Martín-Subero JI
Nat Commun; 2019 Aug; 10(1):3615. PubMed ID: 31399598
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
